OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 02, 2023
Nanoparticles offer the potential for a safer, more effective method of drug delivery to the patient.
March 30, 2023
Takeda received approval in Japan for a subcutaneous injection formulation of Entyvio (vedolizumab) for treating ulcerative colitis.
March 17, 2023
Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.
November 08, 2022
Companies need to consider and address formulation challenges to employ a successful reformulation strategy.
October 02, 2022
There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.
September 16, 2022
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
September 02, 2022
While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.
August 02, 2022
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
November 01, 2021
A coating technology for a staked needle prefillable syringe reduces the potential risks associated with silicone oil as a lubricant.
October 15, 2021
In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.